Evidence map›Paper›PMID 19809473›Full record

ArticleEuropean journal of human genetics : EJHG2010

High-resolution SNP arrays in mental retardation diagnostics: how much do we gain?

Laura Bernardini, Viola Alesi, Sara Loddo, Antonio Novelli, Irene Bottillo, Agatino Battaglia, Maria Cristina Digilio, Giuseppe Zampino, Adam Ertel, Paolo Fortina and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.Genetics in medicine : official journal of the American College of Medical Genetics · 2010
    Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. ASTN2 modulates synaptic strength by trafficking and degradation of surface proteins.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Laura BernardiniCSS Hospital, IRCSS, San Giovanni Rotondo and CSS-Mendel Institute, Rome, Italy.
Viola Alesi
Sara Loddo
Antonio Novelli
Irene Bottillo
Agatino Battaglia
Maria Cristina Digilio
Giuseppe Zampino
Adam Ertel
Paolo Fortina
Saul Surrey
Bruno Dallapiccola
Thomas Jefferson University · USBambino Gesù Children's Hospital · ITFondazione Stella Maris · ITSidney Kimmel Cancer Center · USUniversità Cattolica del Sacro Cuore · IT

Funding

Transactivators of Hb F: Identification and validationR01HL069256 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI SURREY, SAUL · 2003 to 2007
$1.9M
NHLBI NIH HHS HL-69256NHLBI NIH HHS R01 HL069256
6 · The paper itself

Abstract

We used Affymetrix 6.0 GeneChip SNP arrays to characterize copy number variations (CNVs) in a cohort of 70 patients previously characterized on lower-density oligonucleotide arrays affected by idiopathic mental retardation and dysmorphic features. The SNP array platform includes approximately 900,000 SNP probes and 900,000 non-SNP oligonucleotide probes at an average distance of 0.7 Kb, which facilitates coverage of the whole genome, including coding and noncoding regions. The high density of probes is critical for detecting small CNVs, but it can lead to data interpretation problems. To reduce the number of false positives, parameters were set to consider only imbalances >75 Kb encompassing at least 80 probe sets. The higher resolution of the SNP array platform confirmed the increased ability to detect small CNVs, although more than 80% of these CNVs overlapped to copy number 'neutral' polymorphism regions and 4.4% of them did not contain known genes. In our cohort of 70 patients, of the 51 previously evaluated as 'normal' on the Agilent 44K array, the SNP array platform disclosed six additional CNV changes, including three in three patients, which may be pathogenic. This suggests that about 6% of individuals classified as 'normal' using the lower-density oligonucleotide array could be found to be affected by a genomic disorder when evaluated with the higher-density microarray platforms.

Indexed as

Oligonucleotide Array Sequence AnalysisAllelic ImbalanceChildChild, PreschoolCohort StudiesFemaleGenetic VariationGenotypeHumansInfantIn Situ Hybridization, FluorescenceIntellectual DisabilityKaryotypingLoss of HeterozygosityMalePolymerase Chain Reaction

Identifiers

PMID19809473
PMCPMC2987190
OpenAlexW1972112058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.